Metraipolis › archive › dc_d5bbf2fcd393

Anti-SARS-CoV-2 Antibody Development over Four Years in Blood Donors — Europe PMC PMID:41157564

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41157564
DOI: 10.3390/v17101292
License (as archived): solo-consultazione
Archived: 2026-11-09T18:31:33.216Z
SHA-256 of the archived text: de358a64748b3e6df41fa0e92f14022315baafb63fd1018858198a2f7eeacd02
Stable URL of this page: https://metraipolis.com/documento/dc_d5bbf2fcd393

How to cite

Anti-SARS-CoV-2 Antibody Development over Four Years in Blood Donors — Europe PMC PMID:41157564 — Europe PMC (en), https://europepmc.org/article/MED/41157564 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d5bbf2fcd393 (Metraipolis archive dc_d5bbf2fcd393, sha256 de358a64748b3e6df41fa0e92f14022315baafb63fd1018858198a2f7eeacd02)

BibTeX

@misc{dcd5bbf2fcd393,
  title = {Anti-SARS-CoV-2 Antibody Development over Four Years in Blood Donors — Europe PMC PMID:41157564},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41157564},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d5bbf2fcd393; sha256 de358a64748b3e6df41fa0e92f14022315baafb63fd1018858198a2f7eeacd02},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41157564. Agents can read the archived copy with the MCP tool read_document.